Woolley Marie L, Marsden Charles A, Fone Kevin C F
Institute of Neuroscience, School of Biomedical Science, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.
Curr Drug Targets CNS Neurol Disord. 2004 Feb;3(1):59-79. doi: 10.2174/1568007043482561.
The 5-hydroxytryptamine(6) (5-ht(6)) was one of the most recent additions to the 5-HT receptor family, selective antagonists have recently been developed and potential functional roles are now becoming apparent. The high affinity of a wide range of psychiatric drugs for the 5-ht(6)receptor, together with its almost exclusive expression in the CNS, being abundant in limbic and cortical regions, has stimulated significant research interest. The 5-ht(6)receptor appears to regulate glutamatergic and cholinergic neuronal activity, and increasing evidence suggests that it may be involved in the regulation of cognition, feeding and, possibly, affective state and seizures. The current article will review all aspects of the discovery, genetics, distribution, pharmacology and function of the 5-ht(6)receptor. Taken together, this wealth of information warrants the use of the upper case nomenclature for the 5-ht(6) receptor to be approved and its true status recognised.
5-羟色胺(6)(5-HT(6))是5-羟色胺受体家族中最新发现的成员之一,近年来已开发出选择性拮抗剂,其潜在的功能作用也日益明显。多种精神科药物对5-HT(6)受体具有高亲和力,且该受体几乎仅在中枢神经系统中表达,在边缘系统和皮质区域含量丰富,这激发了人们浓厚的研究兴趣。5-HT(6)受体似乎可调节谷氨酸能和胆碱能神经元活动,越来越多的证据表明它可能参与认知、进食的调节,还可能与情感状态及癫痫发作有关。本文将综述5-HT(6)受体在发现、遗传学、分布、药理学及功能等方面的所有内容。综上所述,这些丰富的信息足以使5-HT(6)受体的大写命名法得到认可并确认其真实地位。